SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (1623)6/9/2003 5:43:31 AM
From: Icebrg  Read Replies (1) of 3044
 
Drugs HQ closed after just a month
Sarah Bridge, Mail on Sunday
8 June 2003

[Some more details on the UK part of the cost-cutting operation. Seems very drastic and somewhat unplanned. I wonder what Adams feels about his new job responsibilities?]

AMERICAN drugs giant Millennium Pharmaceuticals is shutting its UK headquarters only one month after moving into the new £30m building in Cambridge.

All 220 staff were made redundant last week after Julian Adams, senior vice-president, flew in to fire the UK employees. They have been told they will have work for another three months and will receive a further three months' pay.

The UK redundancies are part of a drastic cost-cutting exercise by the company, which is slashing its workforce by a quarter. More than 600 people worldwide are to go and its San Francisco office is to shut, leaving only its headquarters in Cambridge, Massachusetts.

Millennium, which lost £356m last year, is to spend less on early research and focus on marketing its blood cancer treatment, Velcade. It said the cuts were needed to hit its targets and turn in profits by 2006.

thisismoney.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext